Response to a letter to the editor entitled ‘Long‐acting relaxin for pulmonary hypertension: From systemic pharmacodynamics to disease‐site pharmacology’
British Journal of Pharmacology · 13.11.2026
DOI: 10.1111/bph.70739 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Pharmacology, online erschienen am 13.11.2026. Verfasst von John Diener und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tectonic Therapeutic, Inc., Watertown, Massachusetts, USA. Die Arbeit nennt 9 Literaturangaben. Gefördert von: Tectonic Therapeutic, Inc.
Abstract (Originalsprache)
Response to a letter to the editor entitled, “Long-acting relaxin for pulmonary hypertension: from systemic pharmacodynamics to disease-site pharmacology”
Autor:innen und Institutionen
- Tectonic Therapeutic, Inc., Watertown, Massachusetts, USA.
Förderung
- Tectonic Therapeutic, Inc
Zitieren
APA
Diener, J., Soni, H., Booe, J., Darce, J., McNamara, P., Ruddy, M., & Muslin, A. J. (2026). Response to a letter to the editor entitled ‘Long‐acting relaxin for pulmonary hypertension: From systemic pharmacodynamics to disease‐site pharmacology’. British Journal of Pharmacology. https://doi.org/10.1111/bph.70739
Vancouver
Diener J, Soni H, Booe J, Darce J, McNamara P, Ruddy M, et al. Response to a letter to the editor entitled ‘Long‐acting relaxin for pulmonary hypertension: From systemic pharmacodynamics to disease‐site pharmacology’. British Journal of Pharmacology. 2026. doi:10.1111/bph.70739
BibTeX
@article{Diener2026,
author = {Diener, John and Soni, Hitesh and Booe, Jason and Darce, Jaime and McNamara, Peter and Ruddy, Marcella and Muslin, Anthony J},
title = {Response to a letter to the editor entitled ‘Long‐acting relaxin for pulmonary hypertension: From systemic pharmacodynamics to disease‐site pharmacology’},
journal = {British Journal of Pharmacology},
year = {2026},
doi = {10.1111/bph.70739}
}
EUVIMED